University of Texas Texas AM Investment Management Co. Acquires 1,009 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)

Key Points

• The University of Texas Texas A&M Investment Management Co. increased its stake in Thermo Fisher Scientific Inc. by 60.7%, owning 2,671 shares valued at approximately $1.33 million at the end of the first quarter.
• Wall Street analysts have mixed views on Thermo Fisher Scientific, with six analysts rating it as a hold while sixteen rated it as a buy, and an average price target now at $593.00.
• Thermo Fisher Scientific announced a quarterly dividend of $0.43, with a current dividend yield of 0.36%, and a payout ratio of 9.95%.

University of Texas Texas AM Investment Management Co. increased its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 60.7% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,671 shares of the medical research company's stock after acquiring an additional 1,009 shares during the period. University of Texas Texas AM Investment Management Co.'s holdings in Thermo Fisher Scientific were worth $1,329,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the stock. Brighton Jones LLC increased its position in shares of Thermo Fisher Scientific by 28.9% during the fourth quarter. Brighton Jones LLC now owns 4,409 shares of the medical research company's stock worth $2,293,000 after purchasing an additional 988 shares in the last quarter. Revolve Wealth Partners LLC grew its holdings in Thermo Fisher Scientific by 4.2% during the fourth quarter. Revolve Wealth Partners LLC now owns 491 shares of the medical research company's stock worth $255,000 after acquiring an additional 20 shares during the period. Bank Pictet & Cie Europe AG grew its position in Thermo Fisher Scientific by 0.3% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 153,157 shares of the medical research company's stock worth $79,677,000 after buying an additional 461 shares during the period. New Age Alpha Advisors LLC acquired a new stake in shares of Thermo Fisher Scientific in the 4th quarter worth approximately $48,000. Finally, Level Four Advisory Services LLC grew its stake in Thermo Fisher Scientific by 14.2% in the 4th quarter. Level Four Advisory Services LLC now owns 1,118 shares of the medical research company's stock valued at $582,000 after acquiring an additional 139 shares during the last quarter. 89.23% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts recently issued reports on TMO shares. Hsbc Global Res lowered shares of Thermo Fisher Scientific from a "strong-buy" rating to a "hold" rating in a research report on Thursday, July 24th. UBS Group boosted their price objective on shares of Thermo Fisher Scientific from $460.00 to $500.00 and gave the stock a "neutral" rating in a report on Thursday, July 24th. Wells Fargo & Company cut their price objective on Thermo Fisher Scientific from $570.00 to $565.00 and set an "overweight" rating on the stock in a research note on Thursday, July 24th. Argus dropped their price target on Thermo Fisher Scientific from $620.00 to $470.00 and set a "buy" rating on the stock in a research report on Tuesday, April 29th. Finally, Barclays increased their price objective on shares of Thermo Fisher Scientific from $450.00 to $490.00 and gave the stock an "equal weight" rating in a report on Thursday, July 24th. Six analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat.com, Thermo Fisher Scientific currently has a consensus rating of "Moderate Buy" and a consensus price target of $593.00.

Insider Activity at Thermo Fisher Scientific

In other news, EVP Gianluca Pettiti sold 400 shares of Thermo Fisher Scientific stock in a transaction on Friday, July 25th. The shares were sold at an average price of $479.98, for a total transaction of $191,992.00. Following the completion of the sale, the executive vice president directly owned 22,367 shares of the company's stock, valued at approximately $10,735,712.66. The trade was a 1.76% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 0.33% of the company's stock.

Thermo Fisher Scientific Trading Up 0.1%

NYSE:TMO traded up $0.31 during trading hours on Thursday, hitting $477.59. 1,734,739 shares of the company were exchanged, compared to its average volume of 2,518,066. The company has a current ratio of 1.93, a quick ratio of 1.50 and a debt-to-equity ratio of 0.65. Thermo Fisher Scientific Inc. has a one year low of $385.46 and a one year high of $627.88. The company has a fifty day simple moving average of $418.15 and a 200 day simple moving average of $468.92. The stock has a market capitalization of $180.28 billion, a price-to-earnings ratio of 27.62, a price-to-earnings-growth ratio of 2.58 and a beta of 0.77.

Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last posted its earnings results on Wednesday, July 23rd. The medical research company reported $5.36 earnings per share for the quarter, topping analysts' consensus estimates of $5.22 by $0.14. Thermo Fisher Scientific had a net margin of 15.24% and a return on equity of 16.82%. The company had revenue of $10.86 billion for the quarter, compared to analyst estimates of $10.68 billion. During the same quarter in the prior year, the business posted $5.37 EPS. The firm's revenue was up 2.9% compared to the same quarter last year. Sell-side analysts expect that Thermo Fisher Scientific Inc. will post 23.28 EPS for the current fiscal year.

Thermo Fisher Scientific Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Monday, September 15th will be given a $0.43 dividend. The ex-dividend date of this dividend is Monday, September 15th. This represents a $1.72 dividend on an annualized basis and a dividend yield of 0.36%. Thermo Fisher Scientific's dividend payout ratio (DPR) is currently 9.95%.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.